↓ Skip to main content

Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity

Overview of attention for article published in Molecular Cancer Therapeutics, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#13 of 3,781)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
34 news outlets
blogs
2 blogs
twitter
33 tweeters

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
18 Mendeley